A soluble form of CTLA‐4 (sCTLA‐4) has also been shown to be increased in systemic lupus erythematosus, myasthenia gravis, and autoimmune thyroid disease.7 This evidence concerns the gene CTLA4 and autoimmune thyroid disease.